Incidence and impact of acute kidney injury on patients with implantable left ventricular assist devices: a Meta-analysis
Charat Thongprayoon(Bassett Medical Center), Kianoush Kashani(WinnMed), Supawat Ratanapo(Phramongkutklao Hospital), Swetha Rani Kanduri(The University of Texas at San Antonio Health Science Center), Narut Prasitlumkum(University of Hawaii System), Panupong Hansrivijit(UPMC Central Pa), Paul W. Davis(Jackson Memorial Hospital), Tibor Fülöp(Medical University of South Carolina), Saraschandra Vallabhajosyula, Karthik Kovvuru(Jackson Memorial Hospital), Kanramon Watthanasuntorn(Bassett Medical Center), Michael A. Mao(Mayo Clinic in Florida), Ploypin Lertjitbanjong(Bassett Medical Center), Wisit Cheungpasitporn(Mayo Clinic), Tarun Bathini(University of Arizona), Ronpichai Chokesuwattanaskul(Chulalongkorn University)
Cited by 29
Related Papers
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
|Nature Reviews Nephrology|2020|703
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference
|JAMA Network Open|2020|644
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
|Kidney International|2020|548